go back

Melanoma Versus Benign Mole Gene Test

New Jersey rates for HCPCS 0314U

Helps decide whether a skin lesion is a melanoma or a harmless mole when its appearance under the microscope is not clear cut. The activity of 35 genes is measured in the stored tissue sample and the lesion is classified accordingly. A companion test instead judges the outlook for squamous cell skin cancers.

Rates data updated July 2026.

Facilitymedian $2,951 · 10th–90th $1,950$14,1250%20%10th90th$2,951Professionalmedian $1,479 · 10th–90th $1,023$1,9500%20%10th90th$1,479$100.0$500.0$2.0K$10.0K$50.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$2,511.89
Median
$2,570.40
Typical High
$12,022.64
Aetna
Setting
Professional
Modifier
Global
Typical Low
$1,071.52
Median
$1,584.89
Typical High
$2,238.72
Cigna
Setting
Facility
Modifier
Global
Typical Low
$2,238.72
Median
$4,265.80
Typical High
$4,570.88
Emblem Health
Setting
Professional
Modifier
Global
Typical Low
$2,041.74
Median
$2,570.40
Typical High
$4,265.80
Horizon BCBS
Setting
Facility
Modifier
Global
Typical Low
$134.90
Median
$11,481.54
Typical High
$25,118.86
Horizon BCBS
Setting
Professional
Modifier
Global
Typical Low
$1,380.38
Median
$1,380.38
Typical High
$1,380.38
United
Setting
Facility
Modifier
Global
Typical Low
$1,174.90
Median
$1,949.84
Typical High
$4,073.80
United
Setting
Professional
Modifier
Global
Typical Low
$812.83
Median
$1,174.90
Typical High
$1,995.26